Mersana Therapeutics, Inc. Intellectual Property Contracts & Agreements

7 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License, Development and Commercialization Agreement, dated July 9, 2015, by and between Mersana Therapeutics, Inc. and Recepta Biopharma S.A
License Agreements
Mersana Therapeutics, Inc.
2023
Amendment No. 1 to the Amended and Restated Commercial License and Option Agreement, dated February 2, 2022, between the Company and Synaffix B.V
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
2022
Amended and Restated Commercial License and Option Agreement, dated November 23, 2021, by and between Synaffix B.V. and Mersana Therapeutics, Inc
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2022
Second Amendment to the License, Development and Commercialization Agreement, dated September 28, 2021, by and between Mersana Therapeutics, Inc. and Recepta Biopharma S.A....
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
2021
Commercial License and Option Agreement
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
MA
2020
First Amendment to the License, Development and Commercialization Agreement dated August 19, 2019, by and between Mersana Therapeutics, Inc. and Recepta Biopharma, S.A
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
2019
CONFIDENTIAL LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT between MERSANA THERAPEUTICS, INC. and RECEPTA BIOPHARMA S.A.
License Agreements
Mersana Therapeutics, Inc.
Biotechnology
NY
2017